The analysis of a cohort of CRC patients revealed a high CD1a+/DC-LAMP+ tumor-infiltrating DC ratio, indicating that there were more iDCs than mature DCs in the CRC tumors (65). The gene discussed is CD1A; the disease is neoplasm.